Anne Wojcicki’s Nonprofit Gets Court Approval to Buy 23andMe for $305 Million
- On June 30, 2025, a U.S. Bankruptcy Court approved the sale of 23andMe's assets to the nonprofit TTAM Research Institute for $305 million.
- The sale follows 23andMe's Chapter 11 bankruptcy filing in March and a competitive bidding process against Regeneron Pharmaceuticals.
- TTAM will acquire 23andMe’s Personal Genome Service, Research Services, and Lemonaid Health, while pledging to uphold customer privacy and provide opt-out options.
- Chair Mark Jensen said the sale approval is a significant milestone enabling 23andMe to transition into a nonprofit and continue its mission to help people benefit from the human genome.
- However, ongoing legal challenges remain, with multiple states, including California, opposing the sale over compliance concerns with genetic privacy laws.
133 Articles
133 Articles

Court approves sale of 23andMe to non-profit led by genetic company’s co-founder and ex-CEO — What Canadian customers should know
In a court order issued on June 27, U.S. bankruptcy judge Brian Walsh approved the sale of 23andMe to nonprofit TTAM Research Institute for US$305 million (C$416 million).
AG Supports 23andMe Sale - ButlerRadio.com - Butler, PA
Pennsylvania Attorney General Dave Sunday is supporting the sale of a bankrupt genetic testing company to a non-profit organization. As part of the bankruptcy process, a court has awarded the genetic data and information held by the genetic testing company 23andMe to a newly formed medical non-profit called TTAM Research Institute. Last month, Sunday’s office joined a bipartisan coalition of states in filing a lawsuit to block 23andMe from selli…
23andMe sale comes with privacy concerns
A bankruptcy court has approved the sale of 23andMe to TTAM Research Institute. In an email sent out to customers on Tuesday, July 1, the genetic testing firm announced the deal is likely to go through by July 8. 23andMe sale TTAM purchased the fledgling company for $305 million after 23andMe filed for bankruptcy back in March. California-based TTAM is led by former 23andMe CEO Anne Wojcicki. “Core to my beliefs is that individuals should be emp…
Coverage Details
Bias Distribution
- 64% of the sources are Center
To view factuality data please Upgrade to Premium